Cheung SY - Search Results

1

Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast.

Tsang JYS, Hui YK, Lee MA, Lacambra M, Ni YB, Cheung SY, Wu C, Kwong A, Tse GMK. Tsang JYS, et al. Among authors: cheung sy. Sci Rep. 2018 Mar 1;8(1):3881. doi: 10.1038/s41598-018-22232-w. Sci Rep. 2018. PMID: 29497099 Free PMC article.

2

Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.

Liu X, Tsang JYS, Hlaing T, Hu J, Ni YB, Chan SK, Cheung SY, Tse GM. Liu X, et al. Among authors: cheung sy. Oncologist. 2017 Nov;22(11):1316-1324. doi: 10.1634/theoncologist.2017-0029. Epub 2017 Jul 12. Oncologist. 2017. PMID: 28701569 Free PMC article.

3

Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis.

Wang Y, Tsang JYS, Cui Y, Cui J, Lin Y, Zhao S, Law PTW, Cheung SY, Ng EKO, Tse GMK, Ke Z. Wang Y, et al. Among authors: cheung sy. Sci Rep. 2017 Jul 28;7(1):6752. doi: 10.1038/s41598-017-07176-x. Sci Rep. 2017. PMID: 28754904 Free PMC article.

4

PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients.

Tsang JY, Au WL, Lo KY, Ni YB, Hlaing T, Hu J, Chan SK, Chan KF, Cheung SY, Tse GM. Tsang JY, et al. Among authors: cheung sy. Breast Cancer Res Treat. 2017 Feb;162(1):19-30. doi: 10.1007/s10549-016-4095-2. Epub 2017 Jan 5. Breast Cancer Res Treat. 2017. PMID: 28058578

5

Predicting Outcome in Mammary Phyllodes Tumors: Relevance of Clinicopathological Features.

Li J, Tsang JY, Chen C, Chan SK, Cheung SY, Wu C, Kwong A, Hu J, Hu H, Zhou D, Tse GM. Li J, et al. Among authors: cheung sy. Ann Surg Oncol. 2019 Sep;26(9):2747-2758. doi: 10.1245/s10434-019-07445-1. Epub 2019 May 20. Ann Surg Oncol. 2019. PMID: 31111353

6

The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas.

Lai BS, Tsang JY, Poon IK, Shao Y, Chan SK, Tam FK, Cheung SY, Shea KH, Tse GM. Lai BS, et al. Among authors: cheung sy. Oncologist. 2020 Sep;25(9):e1318-e1329. doi: 10.1634/theoncologist.2020-0081. Epub 2020 Jun 16. Oncologist. 2020. PMID: 32472950 Free PMC article.

7

Hyaluronan synthase 2 is an adverse prognostic marker in androgen receptor-negative breast cancer.

Zhang H, Tsang JY, Ni YB, Chan SK, Chan KF, Cheung SY, Tse GM. Zhang H, et al. Among authors: cheung sy. J Clin Pathol. 2016 Dec;69(12):1055-1062. doi: 10.1136/jclinpath-2016-203617. Epub 2016 May 11. J Clin Pathol. 2016. PMID: 27169756

8

Expression and Clinical Significance of Herpes Virus Entry Mediator (HVEM) in Breast Cancer.

Tsang JYS, Chan KW, Ni YB, Hlaing T, Hu J, Chan SK, Cheung SY, Tse GM. Tsang JYS, et al. Among authors: cheung sy. Ann Surg Oncol. 2017 Dec;24(13):4042-4050. doi: 10.1245/s10434-017-5924-1. Epub 2017 Jun 13. Ann Surg Oncol. 2017. PMID: 28612127

9

GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer.

Ni YB, Tsang JYS, Shao MM, Chan SK, Cheung SY, Tong J, To KF, Tse GM. Ni YB, et al. Among authors: cheung sy. Breast Cancer Res Treat. 2018 May;169(1):25-32. doi: 10.1007/s10549-017-4645-2. Epub 2018 Jan 16. Breast Cancer Res Treat. 2018. PMID: 29340880

10

CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer.

Liu M, Tsang JYS, Lee M, Ni YB, Chan SK, Cheung SY, Hu J, Hu H, Tse GMK. Liu M, et al. Among authors: cheung sy. J Clin Pathol. 2018 Nov;71(11):1007-1014. doi: 10.1136/jclinpath-2018-205342. Epub 2018 Aug 11. J Clin Pathol. 2018. PMID: 30099407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters